World News

Divarasib in Combination with Cetuximab Demonstrates a Manageable Safety Profile and...

Ogkologos - 20 Δεκεμβρίου, 2023

How My Cancer Diagnosis Has Fueled My Work in Improving Access...

Ogkologos - 19 Δεκεμβρίου, 2023

Osimertinib Shows Promising Activity in Previously Untreated Patients with Metastatic NSCLC...

Ogkologos - 19 Δεκεμβρίου, 2023

Mirvetuximab Soravtansine-gynx Shows a Significant Benefit Over Chemotherapy in Women with...

Ogkologos - 18 Δεκεμβρίου, 2023

Grabbing the Perfect Gift

Ogkologos - 16 Δεκεμβρίου, 2023

Virtual Mind–Body Fitness Classes Show Unexpected Benefit in People with Cancer

Ogkologos - 15 Δεκεμβρίου, 2023

FDA Approves Enzalutamide for Non-Metastatic Castration-Sensitive Prostate Cancer with Biochemical Recurrence

Ogkologos - 15 Δεκεμβρίου, 2023

How We’re Working to Build a Cancer Survivorship Community: Survivors’ Perspectives

Ogkologos - 14 Δεκεμβρίου, 2023

FDA Approves Pembrolizumab with Chemotherapy for HER2-negative Gastric or Gastro-Oesophageal Junction...

Ogkologos - 14 Δεκεμβρίου, 2023

Antibody Drug Ejects Problematic Proteins from Cancer Cells

Ogkologos - 13 Δεκεμβρίου, 2023

1...9899100...432 Σελίδα 99 από 432

MOST POPULAR

New on NCI’s Websites for April 2024

12 Απριλίου, 2024

Judge Rules That 3-Year-Old Child With Leukemia Must Get Chemo Against...

16 Μαΐου, 2019

How Clinical Trials Can Lead to Life-Saving Treatment: The TAPUR Trial...

12 Οκτωβρίου, 2023

Your questions on our research strategy

29 Μαρτίου, 2022

Φόρτωση περισσοτέρων

Divarasib in Combination with Cetuximab Demonstrates a Manageable Safety Profile and...

How My Cancer Diagnosis Has Fueled My Work in Improving Access...

Osimertinib Shows Promising Activity in Previously Untreated Patients with Metastatic NSCLC...

Mirvetuximab Soravtansine-gynx Shows a Significant Benefit Over Chemotherapy in Women with...

Grabbing the Perfect Gift

Virtual Mind–Body Fitness Classes Show Unexpected Benefit in People with Cancer

FDA Approves Enzalutamide for Non-Metastatic Castration-Sensitive Prostate Cancer with Biochemical Recurrence

How We’re Working to Build a Cancer Survivorship Community: Survivors’ Perspectives

FDA Approves Pembrolizumab with Chemotherapy for HER2-negative Gastric or Gastro-Oesophageal Junction...

Antibody Drug Ejects Problematic Proteins from Cancer Cells

MOST POPULAR

New on NCI’s Websites for April 2024

Judge Rules That 3-Year-Old Child With Leukemia Must Get Chemo Against...

How Clinical Trials Can Lead to Life-Saving Treatment: The TAPUR Trial...

Your questions on our research strategy

HOT NEWS

New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer

Studies Show Immunotherapy Improves Long-Term Survival in Growing Number of Cancers

Nivolumab Demonstrates Clinical Benefits in a Statistically Evaluable Number of Patients...

Ivonescimab Plus Chemotherapy Improves OS Compared with Tislelizumab Plus Chemotherapy in...

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ